Cancer is so expensive to treat that 42% of patients deplete their entire life’s assets to afford treatment within the first 2 years says study

Results
Across 9.5 million estimated new diagnoses of cancer from 2000–2012, individuals averaged 68.6±9.4 years with slight majorities being married (54.7%), not retired (51.1%), and Medicare beneficiaries (56.6%). At year+2, 42.4% depleted their entire life’s assets, with higher adjusted odds associated with worsening cancer, requirement of continued treatment, demographic and socioeconomic factors (ie, female, Medicaid, uninsured, retired, increasing age, income, and household size), and clinical characteristics (ie, current smoker, worse self-reported health, hypertension, diabetes, lung disease) (P<.05); average losses were $92,098. At year+4, financial insolvency extended to 38.2%, with several consistent socioeconomic, cancer-related, and clinical characteristics remaining significant predictors of complete asset depletion.

Conclusions
This nationally-representative investigation of an initially-estimated 9.5 million newly-diagnosed persons with cancer who were &#8805;50 years of age found a substantial proportion incurring financial toxicity. As large financial burdens have been found to adversely affect access to care and outcomes among cancer patients, the active development of approaches to mitigate these effects among already vulnerable groups remains of key importance.

We are primarily funded by readers. Please subscribe and donate to support us!

www.godlikeproductions.com/external?https%3A%2F%2Fwww.amjmed.com%2Farticle%2FS0002-9343%2818%2930509-6%2Ffulltext

Views:

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.